Mölnlycke, a global medical products and solutions company, has entered into a new €350m (US$385m) multicurrency revolving credit facility, refinancing an existing and undrawn revolving credit facility signed in 2017. The new facility has a tenor of five years with two one-year extension options and will be used as a backup for general corporate purposes. Seven…
Home Healthcare Markets International Business Sweden: Mölnlycke signs new €350m multicurrency revolving credit facility